HE4 overexpression promotes chemoresistance in ovarian cancer cells

被引：0
|
作者：
Singh, R. [1 ]
Horan, T. [1 ]
Yano, N. [1 ]
Kim, K. [1 ]
Lange, T. [1 ]
Lambert-Messerlian, G. [1 ]
Moore, R. [1 ]
机构：
[1] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
331
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [21] Human epididymis protein 4 (HE4) and ovarian cancer prognosis
    Trudel, Dominique
    Tetu, Bernard
    Gregoire, Jean
    Plante, Marie
    Renaud, Marie-Claude
    Bachvarov, Dimcho
    Douville, Pierre
    Bairati, Isabelle
    GYNECOLOGIC ONCOLOGY, 2012, 127 (03) : 511 - 515
  • [22] Detection of urinary HE4 as a biomarker for epithelial ovarian cancer
    Li, Zhong-Qian
    Radwan, Rachel
    Polkowski, Julie
    Raju, Savitha
    Falcone, Katherine
    Simamora, Rebecca
    Kettlety, Timothy
    Moore, Richard G.
    Barnes, Grady
    CANCER RESEARCH, 2011, 71
  • [23] Validation of urinary HE4 as a biomarker for ovarian cancer.
    Li, Zhong-Qian
    Fermer, Christian
    Radwan, Rachel R.
    Hellman, Maria
    He, Kuanglin
    Falcone, Katherine L.
    Raju, Savitha S.
    Fegely, Maryellen
    Vucetic, Zivjena
    Dickson, Diana L.
    Kettlety, Timothy R.
    Moore, Richard G.
    Barnes, Grady
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Does HE4 have a role in the recurrence of ovarian cancer?
    Montera, Roberto
    Plotti, Francesco
    Muzii, Ludovico
    Terranova, Corrado
    Angelucci, Michela
    Oronzi, Irma
    Damiani, Patrizio
    Dugo, Nella
    Guzzo, Federica
    De Oronzo, Maria Antonietta
    Ricciardi, Roberto
    Aloisi, Alessia
    Luvero, Daniela
    Portuesi, Rosa Alba Valentina
    Scaletta, Giuseppe
    Capriglione, Stella
    Linciano, Francesca
    Gennari, Paolo
    Panici, Pierluigi Benedetti
    Angioli, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Place of HE4 and ROMA score in the diagnosis of ovarian cancer
    Laiche, Naima
    Jayi, Sofia
    Belhaj, Yassine
    Alaoui, Fatima Zohra Fdili
    Chaara, Hekmat
    Melhouf, Moulay Abdelilah
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A404 - A404
  • [26] HE4 IN OVARIAN CANCER: FROM DISCOVERY TO CLINICAL APPLICATION
    Montagnana, M.
    Danese, E.
    Giudici, S.
    Franchi, M.
    Guidi, G. C.
    Plebani, M.
    Lippi, G.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 55, 2011, 55 : 1 - 20
  • [27] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [28] HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells
    James, N. E.
    Cantillo, E.
    Oliver, M. T.
    Rowswell-Turner, R. B.
    Ribeiro, J. R.
    Kim, K. -K.
    Chichester, C. O.
    DiSilvestro, P. A.
    Moore, R. G.
    Singh, R. K.
    Yano, N.
    Zhao, T. C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 193 (03): : 327 - 340
  • [29] Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
    P Zhang
    P Zhang
    B Shi
    M Zhou
    H Jiang
    H Zhang
    X Pan
    H Gao
    H Sun
    Z Li
    Cell Death & Disease, 2014, 5 : e991 - e991
  • [30] Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
    Zhang, P.
    Zhang, P.
    Shi, B.
    Zhou, M.
    Jiang, H.
    Zhang, H.
    Pan, X.
    Gao, H.
    Sun, H.
    Li, Z.
    CELL DEATH & DISEASE, 2014, 5 : e991 - e991
12345